You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Qilu Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?

QILU has thirty-two approved drugs.

There is one tentative approval on QILU drugs.

Summary for Qilu
US Patents:0
Tradenames:29
Ingredients:29
NDAs:32

Drugs and US Patents for Qilu

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qilu Pharm Hainan FOSAPREPITANT DIMEGLUMINE fosaprepitant dimeglumine POWDER;INTRAVENOUS 213106-001 Sep 8, 2020 AP RX No No ⤷  Subscribe ⤷  Subscribe
Qilu Pharm Hainan ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride INJECTABLE;INJECTION 203711-001 Sep 8, 2014 AP RX No Yes ⤷  Subscribe ⤷  Subscribe
Qilu Pharm Hainan OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 204368-002 Jun 7, 2016 AP RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.